Valoctocogene roxaparvovec
id:
valoctocogene-roxaparvovec-285-887347
title:
Valoctocogene roxaparvovec
text:
Valoctocogene roxaparvovec, sold under the brand name Roctavian, is a gene therapy used for the treatment of hemophilia A. It was developed by BioMarin Pharmaceutical. Valoctocogene roxaparvovec is made of a virus (AAV5) that has been modified to contain the gene for factor VIII, which is lacking in people with hemophilia A. It is an adeno-associated virus vector-based gene therapy. It is given by intravenous infusion. The most common side effects include increased levels of the liver enzymes al
brand slug:
wiki
category slug:
encyclopedia
description:
Gene therapy medication for hemophilia A
original url:
https://en.wikipedia.org/wiki/Valoctocogene_roxaparvovec
date created:
date modified:
2023-12-18T06:25:25Z
main entity:
{"identifier":"Q107391591","url":"https://www.wikidata.org/entity/Q107391591"}
image:
fields total:
13
integrity:
14